AI assistant
STAAR SURGICAL CO — Director's Dealing 2023
Mar 11, 2023
31996_dirs_2023-03-10_2c606b7c-f144-4364-b6b8-4c83eee78cf3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2023-03-10
Reporting Person: Barnes Scott D (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-03-10 | Common Stock | F | 285 | $56.63 | Disposed | 30255 | Direct |
| 2023-03-10 | Common Stock | M | 10555 | $0.00 | Acquired | 40810 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-03-10 | Common Stock Options | $56.63 | M | 19301 | Acquired | 2033-03-09 | Common Stock (19301) | Direct |
Footnotes
F1: Award of 10555 Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse as to 1/3 of the RSUs on 3/10/2024, 1/3 of the RSUs on 3/10/2025, and the remaining 1/3 of the RSUs on 3/10/2026.
F2: The options granted become exercisable as follows: 1/3 on 3/10/2024 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/10/2026.